当前课程知识点:Medical Virology > Chapter 4 HIV > 4.5 Treatment, Prevention and Control of HIV/AIDS > Treatment, Prevention and Control of HIV/AIDS
返回《Medical Virology》慕课在线视频课程列表
After the confirmation
明确
of diagnosis,
诊断后
what shall we do to
我们应该
deal with the disease?
如何处理疾病呢?
The patients
患者
need treatment.
需要进行治疗
WHO recommends that
根据世界卫生组织建议
people diagnosed with
HIV感染者
HIV should be offered
应该尽早
and linked to
接受
antiretroviral treatment
抗逆转录病毒治疗
as soon as possible. Antiviral drugs can slow
抗病毒药物
Antiviral drugs can slow
可以减缓
progression of disease.
病程的发展
Thus far, antiviral agents
如今,靶向作用于
targeting various
病毒复制周期不同环节
replication cycle steps
的抗病毒药物有
include:(1)binding, fusion-penetration
病毒入胞、融合
(1)binding,
入胞、融合
fusion-penetration inhibitors,
抑制剂
or (2)integrase inhibitors,
或整合酶抑制剂
or (3)protease inhibitors,
或蛋白酶抑制剂
or (4)nucleoside
或核苷类
analogue reverse
逆转录酶
transcriptase inhibitors,
抑制剂
or non-nucleoside
或非核苷类
reverse transcriptase
逆转录酶
inhibitors,
抑制剂
or (5)CCR5 antagonists.
或CCR5拮抗剂
The drugs are used as a
这些药物可用于
part of a multidrug cocktail,
“鸡尾酒”疗法
we call it as highly active
称为高效
antiretroviral therapy (HAART).
抗逆转录病毒治疗(HAART)
In most cases,
大多数情况下
HAART combines the
HAART治疗中联合
use of three or more
使用三种
anti-HIV drugs from
或三种以上
different classes.
不同类别的抗HIV药物
The good example is the
常联合使用
usage of 1 integrase
1种整合酶抑制剂
inhibitor and 2
和2种核苷类
nucleoside analog RT
逆转录酶抑制剂
inhibitors or 1
或者1种非核苷类
non-nucleoside RT
逆转录酶抑制剂
inhibitor and 2
和2种
nucleoside analog RT
核苷类逆转录酶
inhibitors .
抑制剂
The combination therapy
这种联合治疗方案
can reduce drug
可以降低
resistant,
耐药性
decrease plasma viral
降低血浆中的
load and greatly slow
病毒载量以及
death rate.
降低死亡率
However,
然而
HAART can not eradicate
HAART无法完全清除
the virus and cure AIDS.
病毒并彻底治愈AIDS
The viral reservoirs are
病毒的储存库
hard to overcome.
很难被彻底清除
Sometimes,
某些情况下
immediate treatment
建议马上采取
for Pre-exposure
暴露前
prophylaxis (PrEP) or
预防措施(PrEP)或者
Post-exposure prophylaxis (PEP)
暴露后预防(PEP)
is also suggested.
措施
It may significantly
这可以显著
reduce the odds of infection.
减少感染的可能性
Pre-exposure
暴露前预防
prophylaxis is the latest
是一种在原有联合预防基础上
addition to expand
新增的
combination prevention
预防措施
options for people at
适用于
high risk of HIV infection.
HIV感染高风险人群
Post-exposure
暴露后预防
prophylaxis is a course
是指暴露于
of antiretrovirals
HIV阳性的血液
administered within 48 to
或者生殖道分泌物后
72 hours after exposure
48-72小时内
to HIV-positive blood or
采取抗逆转录病毒
genital secretions.
治疗的措施
Due to the high expense,
因为治疗费用高
the strict adherence,
用药所需的严格的药物依从性
and the side effects,
以及副作用等原因
universal application of
普及使用HAART治疗
HAART is difficult.
难度非常大
The best option to stop
阻断AIDS传播
the spread of AIDS is a
最好的方法是
safe and effective vaccine.
接种安全、高效的疫苗
The question is why
那为什么
haven’t we got an AIDS
到目前为止仍没有有效的
vaccine by now?
AIDS疫苗呢
There are many
制作理想的
challenges in
AIDS疫苗
development of an ideal
要面临许多
vaccine:
挑战
1).HIV mutates rapidly,
1).HIV变异快
creating a moving target
对于免疫应答的建立
for both immune
和疫苗设计来说
response and any
靶标变化
vaccine design.
过快
2).The persistent viral
2).病毒储存库
reservoirs are hard to
很难完全
eliminate.
被清除
3).The vaccine must be
3).制备的疫苗必须能够
designed to elicit neutralizing
有效诱导中和
antibody and
抗体的产生
cell-mediated immunity
和激活细胞免疫
effectively,
应答
avoiding the
同时避免
immunity-mediated
免疫病理
pathogenesis at the
相关的
same time.
致病作用
In addition,
此外
good animal models for
用于疫苗试验的
testing these vaccines
良好动物模型
are limited and expensive.
数量有限且价格昂贵
Anyway,
无论如何
we hope that the
我们希望
scientists take an intense
科学家们能够
effort to devise,
尽最大的努力
test, and deliver a safe
最终制备出
and effective vaccine for
安全、有效的
AIDS ultimately.
艾滋病疫苗
HIV/AIDS has claimed
全世界数百万人因
millions of lives worldwide.
HIV/AIDS失去生命
It is a significant task to
AIDS的防控是
control the disease,
一项重大的任务
hopefully to end
也是结束艾滋病
the epidemic.
流行的希望
What approaches can
我们可以采用什么方法
we take to cope with the task?
进行防控呢?
The essential and
开展关于
effective way of control
HIV传播途径
HIV infection is by
和HIV预防方法
educating the population
的宣传教育
about the methods of
是控制HIV感染
transmission and the
最首要
preventive measures.
最有效的措施
For instance:
例如
Monogamous relationships,
提倡一夫一妻的关系
safe sex,
安全性行为
No needle sharing,
不共用注射器
Strict infection-control
对献血(血液采集)
procedures in blood
和各项医疗操作
banks and healthy-care practice,
实施严格的感染防控措施
A successful anti-HIV
文献表明
education campaign in
在一些发展中国家
some developing
成功的AIDS预防
countries has been cited
宣传教育
as effective as antiviral
与抗病毒治疗一样
drugs for saving lives.
都能有效的拯救生命
There are other ways
其他的防控方法包括
such as overall safety of
保障输血和
blood and blood products,
血液制品以及
circumcision,
包皮环割术的安全
national monitoring.
建立国家监测网
People testing positive
HIV抗体阳性的人
for HIV must not donate blood.
禁止献血
Circumcision of males
实施男性包皮环割术
reduces the risk of infection.
可以降低感染风险
The national monitoring
全球监控
and cooperation is
和地区合作
helpful to campaign for
有助于
global prevention.
全球性预防
On the whole,
总之
in order to defeating HIV/AIDS,
为了战胜HIV/AIDS
UNAIDS proposed one of
联合国艾滋病规划署
the strategies”getting to
提出“零艾滋”战略(2011-2015)
the zero”: zero new infections,
“零艾滋”的内涵为零新增
zero discrimination,
零歧视
zero AIDS related
零AIDS相关
death”(2011-2015).
死亡
Although the goal didn’t
虽然这个目标
reach by 2015,
在2015年未能实现
the campaigns are still
但人类抗击AIDS疫情的工作
on the way.
仍在继续
Through paving ways for
通过在全世界范围内
prevention and
实施广泛的
education programs
预防和宣传教育
around the world,
措施
expanding drug access
提高药物使用的
programs,
普遍性
speeding up vaccine development,
加快疫苗研制
strengthening the cooperation,
加强地区合作
etc,
等等
ending the AIDS
未来,消灭AIDS
epidemic is possible.
将成为可能
At this time,
现在
we have finished all the key
我们已经学完了HIV的
contents of HIV.
主要内容
Here are main
表格中是
summaries in the table.
一些重要内容的总结
You can review them and
同学们可以结合学习目标
connect the leaning
回顾这些内容
objectives for further
由此更好地
comprehension.
理解
Finally,
最后
there is a case for you.
给同学们一个案例
Draw a mindmap to
请完成这个案例的
analyse the case.
思维导图
Here is the list of the
以下是参考书目
reference books and
以及
websites cited.
引用内容的网址
Thank you for your attention!
感谢同学们的聆听
-Learning Objectives & References
-Assessment Plan of Medical Virology
-To apply basics to clinical case
-1.1 Viral Structure and Composition
--Viral Structure and Composition
--Shapes and relative sizes of viruses
-1.2 Viral Replication
-1.3 Viral Genetics and Classification
--Viral Genetics and Classification
-1.4 Pathogenesis of Viral infection
--Pathogenesis of Viral infection
-1.5 Lab Diagnosis and Host Rsponse to Viral Infection
--Lab Dignosis and Host Rsponse to Viral Infection
-General Virology Quiz
-2.1 Influenza Virus: Biological Properties 1
--Influenza Virus: Biological Properties 1
-2.2 Influenza Virus: Biological Properties 2
--Influenza Virus: Biological Properties 2
-2.3 Influenza Virus: Biological Properties 3
--Influenza Virus: Biological Properties 3
-2.4 Influenza Virus: Lab, Treatment and Prevention
--Influenza Virus: Lab, Treatment and Prevention
-2.5 Paramyxovirus
-2.6 Coronavirus and Rubella virus
--Coronavirus and Rubella virus
-Viruses Transmitted Through Respiratory Route Quiz
-3.1 Diseases Caused by Enteroviruses
--Diseases Caused by Enteroviruses
-3.2 Poliovirus Infection and Viron of Enterovirus
--Poliovirus Infection and Viron of Enterovirus
-3.3 Lab Diagnosis & Prevention of Enterovirus
--Lab Diagnosis & Prevention of Enterovirus
-3.4 Viruses Causing Acute Gastroenteritis
--Viruses Causing Acute Gastroenteritis
-Viruses Transmitted Through Fecal-oral Route Quiz
-4.1 General Properties of HIV
-4.2 Replication of HIV
-4.3 Pathogenesis and Immunity of HIV
--Pathogenesis and Immunity of HIV
-4.4 Epidemiology and Lab Diagnosis of HIV/AIDS
--Epidemiology and Lab Diagnosis of HIV/AIDS
-4.5 Treatment, Prevention and Control of HIV/AIDS
--Treatment, Prevention and Control of HIV/AIDS
-HIV Quiz
-5.1 HSV
--HSV
-5.2 VZV
--VZV
-5.3 EBV, CMV and HHV 6-8
-Herpes Viruses Quiz
-6.1 HAV and HEV
-6.2 HBV, HCV and HDV
-Hepatitis Viruses Quiz
-7.1 Arbovirus
-7.2 Hemorrhagic Fever Virus
-7.3 Rabies Virus
-7.4 HPV
--HPV
-7.5 Prion
--Prion
-Other Important Human Viruses Quiz